Diskus

DEVICE4 trials

Sponsors

Pfizer, GlaxoSmithKline

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 2

A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation

CompletedNCT02522299

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2015-11-04End: 2018-06-22Updated: 2021-09-05

Phase 3

DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT01868009

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2013-05-31End: 2013-07-31Updated: 2014-03-04

Unknown Phase

Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung Obstruction

CompletedNCT01033669

PfizerAsthma, Pulmonary Disease, Chronic Obstructive

Start: 2009-11-30End: 2010-02-28Updated: 2010-03-17

Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness

CompletedNCT03543176

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2018-05-31End: 2019-08-21Updated: 2020-08-05